Search

everythinglearnresearchcommunity

for

Search:↓

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Pix Liquida helped a man recover from patchy hair loss.

Baicalin may help reduce excessive male hormone levels in PCOS.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Early diagnosis and treatment can reduce cicatricial alopecia in middle-aged individuals, especially females.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

ICP5249 helps hair grow by activating a specific cell pathway.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Elagolix did not effectively treat polycystic ovary syndrome.

AMP-303 safely increases hair growth in men with hair loss.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

New method accurately measures finasteride in tablets and bulk.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

A reliable method was created to measure dutasteride and related molecules in capsules.

Calancardin B may help reduce inflammation in immune cells.

Linagliptin may cause hair loss and skin blisters.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.